ArticleCancer immunology, immunotherapy : CII2026
Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma.
Tan-Chi Fan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.